Connect
← Return to Why getting infected with COVID-19 is still a bad idea
Newsfeed PostNewsfeed Post in blog Podcasts
Why getting infected with COVID-19 is still a bad idea Feb 2, 2022 | By Jennifer O'Hara (@jenohara)Comment receiving replies
My liver team at Mount Sinai called me and
Want me to have this drug called Evusheld.
Cilgavimab n tixagevimab together for
Immunosuppressive patients . It is administered by two shots in the arm. Only given at hospital thru the infectious medical team. This has been approved as an emergency treatment against covid by the Cda and fda. Has any one come across this information? THANKS, JACKIE
Replies to "My liver team at Mount Sinai called me and Want me to have this drug called..."
Jackie, as a transplant patient, you'll be interested in following this related discussion with fellow transplant recipients:
- Just approved: Evusheld for the pre-exposure prevention of COVID-19 https://connect.mayoclinic.org/discussion/evusheld/
Connect
The following information was put up on the Mayo Clinic site on Wednesday, January 19, 2022: “The Emergency Use for Evushield is for pre exposure prophylaxis to recent Covid in people immunocompromised or allergic to the vaccine.” It looks like you are not able to benefit from the vaccine so they are giving this to you to protect you from getting very sick if you are exposed to Covid. Evushield is a combination of two medicines. Call 1-800-236-9933 if you have more questions. I am happy for you that you are being offered this, to keep you as healthy as possible.